Patient Recruitment/Retention Featured Articles
-
Debra Weiss, RN: Big Impact In Small, Non-Profit Bio
3/8/2024
The career of Debra Weiss, RN, MSN, and COO at the biopharma Gates Medical Research Institute (Gates MRI), offers a case study in creating success through service-oriented leadership.
-
Is Ignoring Gender Non-Conformity Research Holding Us Back?
3/4/2024
Including individuals across the gender spectrum in clinical trials isn't just the right thing to do, it's also strategic move with benefits for science, society, and business.
-
Do ClinOps Professionals Understand The CAR-T Supply Chain?
3/4/2024
Lee Clough RN, HP, of Novartis talks about the importance of understanding the nuances associated with collecting and shipping autologous material (i.e., CAR-Ts) for clinical trials.
-
Tokenism In Clinical Trials For Rare Disease Patients
2/29/2024
While recent efforts promote diversity in clinical trials, the lack of enforcement and tokenistic approaches risk leaving people of color behind. This article delves into the urgency of addressing this crisis and building genuine inclusivity for a healthier future for all.
-
Post-Pandemic Planning: Using Direct-To-Patient Deliveries For Supply Chain Management
2/23/2024
UCB Vice President – Head of Global Clinical Science and Operations Tero Laulajainen gets us up to speed on direct-to-patient (DTP) trials and how UCB is leveraging it today.
-
4 Things I Learned At SCOPE 2024
2/21/2024
The Summit for Clinical Ops Executives (SCOPE) ran from Feb. 11-4. Discover four things Executive Editor Abby Proch learned at the annual event.
-
Addressing Underrepresentation In Cancer Trials: A Q&A With Stand Up To Cancer & Triage Cancer
2/13/2024
Clinical Leader heard from both sides of the collaboration — SU2C researcher Dr. Chanita Hughes-Halbert, Ph.D., and grant recipient Triage Cancer co-founder and COO Monica Fawzy Bryant, Esq. — to explore each’s efforts to together bring health equity to those diagnosed with cancer.
-
FDA Guidance On Standardizing Diversity And Inclusion Terminology And Collection
2/9/2024
Last week, the FDA issued a new draft guidance titled Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products.
-
Incorporating SOGI Data In Clinical Research And Impacts On Enhancing Cancer Treatment Outcomes
2/2/2024
Collecting and measuring SOGI information in cancer care and clinical trials is critical to ensuring equitable and effective care for all individuals.
-
4 Things I’m Looking Forward To At SCOPE 2024
2/1/2024
The Summit for Clinical Ops Executives (SCOPE) begins Feb. 11. Discover four things Executive Editor Abby Proch is looking forward to at the annual event.